Hearing on Biotech Medicine Prices

The Oversight Committee is currently holding a hearing to examine the high cost of biotech medicines to our health care system, as well the prospects and need for a pathway that would allow the FDA to approve safe and affordable generic versions… Continue

More Problems at GSA

Three weeks ago we covered the efforts of the Oversight and Government Reform Committee to examine a no-bid contract awarded by the General Services Administration to Edie Fraser, with whom GSA Administrator Doan had a longstanding personal and business relationship. The Committee… Continue

Political Interference & the Tobacco Industry

Prosecutor Says Bush Appointees Interfered With Tobacco Case Carol D. Leonnig, Washington Post – March 22, 2007 From the Committee on Oversight and Government Reform: Information Requested on Allegations of Political Interference in Tobacco Case Following renewed allegations of political interference in… Continue

Debate on Rules for the Iraq Accountability Act

H.Res. 261, the rule providing for consideration of the U.S. Troop Readiness, Veterans’ Health and Iraq Accountability Act, has just passed, 225-201. Rep. Louise Slaughter (NY-28), Chair of the Rules Committee, opened the debate on the rule (debate on the bill itself… Continue

Newsletter Signup